YiChang HEC ChangJiang Pharmaceutical Co., Ltd.
YIHCF · OTC
12/31/2024 | 6/30/2024 | 12/31/2023 | 6/30/2023 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.03 | -0.05 | -0.13 | 0.00 |
| FCF Yield | -20.25% | -10.73% | 8.71% | 29.33% |
| EV / EBITDA | -0.55 | 0.48 | 2.92 | 2.53 |
| Quality | ||||
| ROIC | -1.51% | 6.52% | 8.57% | 11.74% |
| Gross Margin | 66.57% | 79.41% | 78.49% | 79.90% |
| Cash Conversion Ratio | -0.60 | 0.04 | 0.44 | 1.21 |
| Growth | ||||
| Revenue 3-Year CAGR | 5.33% | 6.26% | 4.75% | 5.54% |
| Free Cash Flow Growth | -89.46% | -225.71% | -70.82% | -18.77% |
| Safety | ||||
| Net Debt / EBITDA | -0.10 | 0.09 | 0.62 | 0.42 |
| Interest Coverage | -1.98 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.66 | 0.87 | 1.62 | 1.82 |
| Cash Conversion Cycle | 252.30 | 91.17 | 88.79 | 54.69 |